Literature DB >> 7886767

Serum procalcitonin concentrations in acute malaria.

T M Davis1, M Assicot, C Bohuon, A St John, G Q Li, T K Anh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7886767     DOI: 10.1016/0035-9203(94)90221-6

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  8 in total

1.  A brief history of procalcitonin.

Authors:  C Bohuon
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

Review 2.  [Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients].

Authors:  M Hochreiter; S Schroeder
Journal:  Anaesthesist       Date:  2011-07       Impact factor: 1.041

3.  High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis.

Authors:  Y Gérard; D Hober; S Petitjean; M Assicot; C Bohuon; Y Mouton; P Wattré
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

Review 4.  Clinical Utility and Measurement of Procalcitonin.

Authors:  Intan Samsudin; Samuel D Vasikaran
Journal:  Clin Biochem Rev       Date:  2017-04

5.  Elevated calcitonin precursor levels are related to mortality in an animal model of sepsis.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

6.  Procalcitonin, a marker of bacterial infection.

Authors:  D Gendrel; C Bohuon
Journal:  Infection       Date:  1997 May-Jun       Impact factor: 3.553

7.  Procalcitonin as a biomarker for severe Plasmodium falciparum disease: a critical appraisal of a semi-quantitative point-of-care test in a cohort of travellers with imported malaria.

Authors:  Dennis A Hesselink; Jan-Steven Burgerhart; Hanna Bosmans-Timmerarends; Pieter Petit; Perry J J van Genderen
Journal:  Malar J       Date:  2009-09-01       Impact factor: 2.979

8.  Procalcitonin serum levels in tertian malaria.

Authors:  Christoph Manegold; Stefan Schmiedel; Collins B Chiwakata; Manfred Dietrich
Journal:  Malar J       Date:  2003-10-16       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.